BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aithal GP. Hepatotoxicity related to antirheumatic drugs.Nat Rev Rheumatol. 2011;7:139-150. [PMID: 21263458 DOI: 10.1038/nrrheum.2010.214] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Tang KT, Hung WT, Chen YH, Lin CH, Chen DY. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B. Sci Rep 2016;6:22387. [PMID: 26928373 DOI: 10.1038/srep22387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
2 Rowe BW, Gala-Lopez B, Tomlinson C, Girgis S, Shapiro JA. Fulminant hepatic failure necessitating transplantation following the initiation of infliximab therapy: a cautionary tale times two. Transpl Int 2013;26:e110-2. [PMID: 24047326 DOI: 10.1111/tri.12185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Bedoui Y, Guillot X, Sélambarom J, Guiraud P, Giry C, Jaffar-Bandjee MC, Ralandison S, Gasque P. Methotrexate an Old Drug with New Tricks. Int J Mol Sci 2019;20:E5023. [PMID: 31658782 DOI: 10.3390/ijms20205023] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 17.3] [Reference Citation Analysis]
4 M S, B P, Swaminathan P. An in silico Workflow that Yields Experimentally Comparable Inhibitors for Human Dihydroorotate Dehydrogenase. Curr Comput Aided Drug Des 2020;16:340-50. [PMID: 31132976 DOI: 10.2174/1573409915666190528114703] [Reference Citation Analysis]
5 Selvaraj S, Oh JH, Borlak J. An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac. Arch Toxicol 2020;94:2733-48. [PMID: 32372211 DOI: 10.1007/s00204-020-02767-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Selvaraj S, Oh JH, Spanel R, Länger F, Han HY, Lee EH, Yoon S, Borlak J. The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury. Oncotarget 2017;8:107763-824. [PMID: 29296203 DOI: 10.18632/oncotarget.21201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Üsküdar Cansu D, Öztaş E, Yilmaz E, Korkmaz C. Cyclophosphamide-induced severe acute hepatitis in a rheumatic disease: case-based review. Rheumatol Int 2019;39:377-85. [DOI: 10.1007/s00296-018-4189-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Chen P, Chen C, Hu M, Cui R, Liu F, Yu H, Ren Y. S-allyl-L-cysteine protects hepatocytes from indomethacin-induced apoptosis by attenuating endoplasmic reticulum stress. FEBS Open Bio 2020;10:1900-11. [PMID: 32790969 DOI: 10.1002/2211-5463.12945] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Mazza S, Soro S, Verga MC, Elvo B, Ferretti F, Cereatti F, Drago A, Grassia R. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World J Hepatol 2021; 13(12): 1828-1849 [DOI: 10.4254/wjh.v13.i12.1828] [Reference Citation Analysis]
10 Eun Y, Kim IY, Jeong H, Kim H, Lee J, Choi MS, Koh E, Cha HS. Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study. J Korean Med Sci 2018;33:e168. [PMID: 29853822 DOI: 10.3346/jkms.2018.33.e168] [Reference Citation Analysis]
11 Chi ZC. Research status and progress of drug induced liver injury. Shijie Huaren Xiaohua Zazhi 2021; 29(16): 915-925 [DOI: 10.11569/wcjd.v29.i16.915] [Reference Citation Analysis]
12 Tang KT, Chen YM, Chang SN, Lin CH, Chen DY. Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan. J Am Acad Dermatol 2018;79:652-8. [PMID: 29753054 DOI: 10.1016/j.jaad.2018.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
13 Grove JI, Aithal GP. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology. Expert Opin Drug Metab Toxicol 2015;11:395-409. [PMID: 25491399 DOI: 10.1517/17425255.2015.992414] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
14 Wei S, Ma W, Zhang B, Li W. NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity. Front Cell Dev Biol 2021;9:634607. [PMID: 33912556 DOI: 10.3389/fcell.2021.634607] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Donato M, Tolosa L. High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells. Antioxidants (Basel) 2021;10:106. [PMID: 33451093 DOI: 10.3390/antiox10010106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
16 Muehler A, Kohlhof H, Groeppel M, Vitt D. The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study. Drugs R D 2019;19:351-66. [PMID: 31621054 DOI: 10.1007/s40268-019-00286-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
17 Busger Op Vollenbroek FTM, Doggen CJM, Janssens RWA, Bernelot Moens HJ. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines. PLoS One 2018;13:e0194401. [PMID: 29570708 DOI: 10.1371/journal.pone.0194401] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
18 Kim J, Kim Y, Choi J, Jung H, Lee K, Kang J, Park N, Rim YA, Nam Y, Ju JH. Recapitulation of methotrexate hepatotoxicity with induced pluripotent stem cell-derived hepatocytes from patients with rheumatoid arthritis. Stem Cell Res Ther 2018;9:357. [PMID: 30594247 DOI: 10.1186/s13287-018-1100-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
19 Kaliyaperumal K, Grove JI, Delahay RM, Griffiths WJH, Duckworth A, Aithal GP. Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications.J Hepatol. 2018;69:948-957. [PMID: 29792895 DOI: 10.1016/j.jhep.2018.05.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
20 Golds G, Worobetz L. Fulminant Hepatic Failure in a Patient with Crohn's Disease on Infliximab Possibly Related to Reactivation of Herpes Simplex Virus 2 Infection. Case Reports Hepatol 2016;2016:2132056. [PMID: 27818806 DOI: 10.1155/2016/2132056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Kamchatnov PR. [Improvement of the efficacy and safety of the treatment of patients with low back pain]. Zh Nevrol Psikhiatr Im S S Korsakova 2016;116:28-33. [PMID: 27845312 DOI: 10.17116/jnevro201611610128-33] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
22 Chiu YM, Lai MS, Chan KA. Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections. PLoS One 2018;13:e0196210. [PMID: 29694398 DOI: 10.1371/journal.pone.0196210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Vorrink SU, Zhou Y, Ingelman-Sundberg M, Lauschke VM. Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions. Toxicol Sci 2018;163:655-65. [PMID: 29590495 DOI: 10.1093/toxsci/kfy058] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 23.3] [Reference Citation Analysis]
24 Alamri RD, Elmeligy MA, Albalawi GA, Alquayr SM, Alsubhi SS, El-Ghaiesh SH. Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review. Int Immunopharmacol 2021;93:107398. [PMID: 33571819 DOI: 10.1016/j.intimp.2021.107398] [Reference Citation Analysis]
25 Choudhary NS, Gupta S, Chawla YK, Duseja A, Dhiman RK, Das A. Azathioprine induced liver injury: a case report. Dig Dis Sci 2012;57:1717-8. [PMID: 22526581 DOI: 10.1007/s10620-012-2056-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Çakır T, Özkan E, Dulundu E, Topaloğlu Ü, Şehirli AÖ, Ercan F, Şener E, Şener G. Caffeic acid phenethyl ester (CAPE) prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pharm Pharmacol 2011;63:1566-71. [PMID: 22060287 DOI: 10.1111/j.2042-7158.2011.01359.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
27 Sahu CR. Mechanisms Involved in Toxicity of Liver Caused by Piroxicam in Mice and Protective Effects of Leaf Extract of Hibiscus rosa-sinensis L. Clin Med Insights Arthritis Musculoskelet Disord 2016;9:9-13. [PMID: 26819562 DOI: 10.4137/CMAMD.S29463] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Yan D, Borucki R, Sontheimer RD, Werth VP. Candidate drug replacements for quinacrine in cutaneous lupus erythematosus. Lupus Sci Med 2020;7:e000430. [PMID: 33082164 DOI: 10.1136/lupus-2020-000430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Ortega-Alonso A, Andrade RJ. Chronic liver injury induced by drugs and toxins. J Dig Dis 2018;19:514-21. [PMID: 29808546 DOI: 10.1111/1751-2980.12612] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Aithal GP. Hepatotoxicity Related to Methotrexate. Drug-Induced Liver Disease. Elsevier; 2013. pp. 593-604. [DOI: 10.1016/b978-0-12-387817-5.00032-7] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
31 Xuan J, Ren Z, Qing T, Couch L, Shi L, Tolleson WH, Guo L. Mitochondrial dysfunction induced by leflunomide and its active metabolite. Toxicology 2018;396-397:33-45. [PMID: 29427785 DOI: 10.1016/j.tox.2018.02.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
32 Kelleni MT, Ibrahim SA, Abdelrahman AM. Effect of captopril and telmisartan on methotrexate-induced hepatotoxicity in rats: impact of oxidative stress, inflammation and apoptosis. Toxicol Mech Methods. 2016;26:371-377. [PMID: 27269004 DOI: 10.1080/15376516.2016.1191576] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
33 Shahzad K, Mushtaq S, Rizwan M, Khalid W, Atif M, Din FU, Ahmad N, Abbasi R, Ali Z. Field-controlled magnetoelectric core-shell CoFe2O4@BaTiO3 nanoparticles as effective drug carriers and drug release in vitro. Mater Sci Eng C Mater Biol Appl 2021;119:111444. [PMID: 33321584 DOI: 10.1016/j.msec.2020.111444] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
34 Elshaer RE, Tawfik MK, Nosseir N, El-ghaiesh SH, Toraih EA, Elsherbiny NM, Zaitone SA. Leflunomide-induced liver injury in mice: Involvement of TLR4 mediated activation of PI3K/mTOR/NFκB pathway. Life Sciences 2019;235:116824. [DOI: 10.1016/j.lfs.2019.116824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
35 Oda S, Shirai Y, Akai S, Nakajima A, Tsuneyama K, Yokoi T. Toxicological role of an acyl glucuronide metabolite in diclofenac-induced acute liver injury in mice. J Appl Toxicol 2017;37:545-53. [PMID: 27671914 DOI: 10.1002/jat.3388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
36 Singh D, Cho WC, Upadhyay G. Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview. Front Physiol 2015;6:363. [PMID: 26858648 DOI: 10.3389/fphys.2015.00363] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
37 Chiu YM, Lai MS, Chan KA. Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study. Arthritis Res Ther 2017;19:214. [PMID: 29089055 DOI: 10.1186/s13075-017-1413-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Cho YE, Moon PG, Baek MC. An integrated proteomic and transcriptomic approach to understanding azathioprine- induced hepatotoxicity in rat primary hepatocytes. Electrophoresis 2014;35:911-22. [PMID: 24338571 DOI: 10.1002/elps.201300137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
39 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 155] [Article Influence: 66.0] [Reference Citation Analysis]
40 van Swelm RP, Laarakkers CM, Kooijmans-otero M, de Jong EM, Masereeuw R, Russel FG. Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients. Toxicology Letters 2013;221:219-24. [DOI: 10.1016/j.toxlet.2013.06.234] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
41 Li YC, Shen JD, Lu SF, Zhu LL, Wang BY, Bai M, Xu EP. Transcriptomic analysis reveals the mechanism of sulfasalazine-induced liver injury in mice. Toxicol Lett 2020;321:12-20. [PMID: 31830553 DOI: 10.1016/j.toxlet.2019.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
42 Abdeen A, Aboubakr M, Elgazzar D, Abdo M, Abdelkader A, Ibrahim S, Elkomy A. Rosuvastatin attenuates piroxicam-mediated gastric ulceration and hepato-renal toxicity in rats. Biomedicine & Pharmacotherapy 2019;110:895-905. [DOI: 10.1016/j.biopha.2018.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
43 Seeland S, Török M, Kettiger H, Treiber A, Hafner M, Huwyler J. A cell-based, multiparametric sensor approach characterises drug-induced cytotoxicity in human liver HepG2 cells. Toxicology in Vitro 2013;27:1109-20. [DOI: 10.1016/j.tiv.2013.02.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
44 Taskin B, Erdoğan MA, Yiğittürk G, Günenç D, Erbaş O. Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model. Gastroenterol Res Pract 2017;2017:7942531. [PMID: 28912805 DOI: 10.1155/2017/7942531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Zhao L, Russo DP, Wang W, Aleksunes LM, Zhu H. Mechanism-Driven Read-Across of Chemical Hepatotoxicants Based on Chemical Structures and Biological Data. Toxicol Sci 2020;174:178-88. [PMID: 32073637 DOI: 10.1093/toxsci/kfaa005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
46 Yarur AJ, Czul F, Levy C. Hepatobiliary manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1655-1667. [PMID: 24874461 DOI: 10.1097/mib.0000000000000065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
47 Lin YC, Chen YJ, Lee SW, Lee TY, Chen YH, Huang WN, Yang SS, Chen YM. Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy. J Clin Med 2021;10:3296. [PMID: 34362079 DOI: 10.3390/jcm10153296] [Reference Citation Analysis]
48 Zhang H, Qian M, Wang J, Yang G, Weng Y, Jin C, Li Y, Jin Y. Insights into the effects of difenoconazole on the livers in male mice at the biochemical and transcriptomic levels. J Hazard Mater 2022;422:126933. [PMID: 34425431 DOI: 10.1016/j.jhazmat.2021.126933] [Reference Citation Analysis]
49 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci. 2016;17. [PMID: 27187363 DOI: 10.3390/ijms17050714] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
50 Tang KT, Lin CC, Lin SC, Wang JH, Tsai SW. Kurarinone Attenuates Collagen-Induced Arthritis in Mice by Inhibiting Th1/Th17 Cell Responses and Oxidative Stress. Int J Mol Sci 2021;22:4002. [PMID: 33924467 DOI: 10.3390/ijms22084002] [Reference Citation Analysis]
51 Moggs J, Moulin P, Pognan F, Brees D, Leonard M, Busch S, Cordier A, Heard DJ, Kammüller M, Merz M, Bouchard P, Chibout S. Investigative safety science as a competitive advantage for Pharma. Expert Opinion on Drug Metabolism & Toxicology 2012;8:1071-82. [DOI: 10.1517/17425255.2012.693914] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
52 Ikemura K, Hiramatsu SI, Shinogi Y, Nakatani Y, Tawara I, Iwamoto T, Katayama N, Okuda M. Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein. Sci Rep 2019;9:20359. [PMID: 31889141 DOI: 10.1038/s41598-019-56900-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
53 Burmester GR, Winthrop K, Blanco R, Nash P, Goupille P, Azevedo VF, Salvarani C, Rubbert-Roth A, Lesser E, Lippe R, Lertratanakul A, Mccaskill RM, Liu J, Ruderman EM. Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials. Rheumatol Ther 2021. [PMID: 34970731 DOI: 10.1007/s40744-021-00410-z] [Reference Citation Analysis]
54 Zhang X, Li C, Gong Z. Development of a convenient in vivo hepatotoxin assay using a transgenic zebrafish line with liver-specific DsRed expression. PLoS One 2014;9:e91874. [PMID: 24626481 DOI: 10.1371/journal.pone.0091874] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
55 Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells 2020;9:E880. [PMID: 32260219 DOI: 10.3390/cells9040880] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
56 Tang KT, Chen YH, Lin CH, Chen DY. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C. Sci Rep 2016;6:33104. [PMID: 27609026 DOI: 10.1038/srep33104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
57 Aithal GP. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice. Liver Int. 2015;35:1801-1808. [PMID: 25809692 DOI: 10.1111/liv.12836] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
58 Parisi I, O'Beirne J, Rossi RE, Tsochatzis E, Manousou P, Theocharidou E, Hamilton M, Murray C, Epstein O, Burroughs AK. Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab. Eur J Gastroenterol Hepatol 2016;28:786-91. [PMID: 27015138 DOI: 10.1097/MEG.0000000000000624] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
59 Reuben A. Hepatotoxicity of Immunosuppressive Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 569-91. [DOI: 10.1016/b978-0-12-387817-5.00031-5] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
60 Jones SW, Penman SL, French NS, Park BK, Chadwick AE. Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models. Toxicol In Vitro 2021;72:105096. [PMID: 33460737 DOI: 10.1016/j.tiv.2021.105096] [Reference Citation Analysis]
61 Lewis JH, Stine JG. Nonsteroidal Antiinflammatory Drugs and Leukotriene Receptor Antagonists. Drug-Induced Liver Disease. Elsevier; 2013. pp. 369-401. [DOI: 10.1016/b978-0-12-387817-5.00022-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
62 Sandoval G, Quintana PG, Baldessari A, Ballesteros AO, Plou FJ. Lipase-catalyzed preparation of mono- and diesters of ferulic acid. Biocatalysis and Biotransformation 2015;33:89-97. [DOI: 10.3109/10242422.2015.1060228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
63 Oraebosi MI, Good GM, Chia T, Oyeniran OI. Bombax Costatum extract abrogates piroxicam-mediated hepatic and gastric toxicities in rats. Ann Pharm Fr 2020;78:507-14. [PMID: 32565156 DOI: 10.1016/j.pharma.2020.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Abdeen A, Abou-Zaid OA, Abdel-Maksoud HA, Aboubakr M, Abdelkader A, Abdelnaby A, Abo-Ahmed AI, El-Mleeh A, Mostafa O, Abdel-Daim M, Aleya L. Cadmium overload modulates piroxicam-regulated oxidative damage and apoptotic pathways. Environ Sci Pollut Res Int 2019;26:25167-77. [PMID: 31256392 DOI: 10.1007/s11356-019-05783-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
65 Rutherford A, Nikiphorou E, Galloway J. Rheumatoid Arthritis. In: El Miedany Y, editor. Comorbidity in Rheumatic Diseases. Cham: Springer International Publishing; 2017. pp. 53-79. [DOI: 10.1007/978-3-319-59963-2_3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
66 Ortolan A, Lorenzin M, Tadiotto G, Russo FP, Oliviero F, Felicetti M, D’incà R, Favero M, Piaserico S, Doria A, Ramonda R. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. Clin Rheumatol 2019;38:2843-50. [DOI: 10.1007/s10067-019-04646-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
67 Cha HJ, Ahn J, Jeong J, Park M, Kim EJ, Kang H, Kim HS, Seong W, Jeong H. Identification of modulated mRNAs and proteins in human primary hepatocytes treated with non-steroidal anti-inflammatory drugs. Mol Cell Toxicol 2015;11:335-42. [DOI: 10.1007/s13273-015-0033-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
68 Lee EH, Oh JH, Selvaraj S, Park SM, Choi MS, Spanel R, Yoon S, Borlak J. Immunogenomics reveal molecular circuits of diclofenac induced liver injury in mice. Oncotarget 2016;7:14983-5017. [PMID: 26934552 DOI: 10.18632/oncotarget.7698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
69 Abdelaziz AI, Mantawy EM, Gad AM, Fawzy HM, Azab SS. Activation of pCREB/Nrf-2 signaling mediates re-positioning of liraglutide as hepato-protective for methotrexate -induced liver injury (MILI). Food Chem Toxicol 2019;132:110719. [PMID: 31362085 DOI: 10.1016/j.fct.2019.110719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
70 Heidari R, Sadeghi N, Azarpira N, Niknahad H. Sulfasalazine-Induced Hepatic Injury in an Ex Vivo Model of Isolated Perfused Rat Liver and the Protective Role of Taurine. Pharm Sci 2015;21:211-9. [DOI: 10.15171/ps.2015.39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
71 Dragovic S, Boerma JS, Vermeulen NPE, Commandeur JNM. Effect of Human Glutathione S -Transferases on Glutathione-Dependent Inactivation of Cytochrome P450-Dependent Reactive Intermediates of Diclofenac. Chem Res Toxicol 2013;26:1632-41. [DOI: 10.1021/tx400204d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
72 Roth AD, Lee MY. Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays. Biomed Res Int 2017;2017:9176937. [PMID: 28133614 DOI: 10.1155/2017/9176937] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
73 Feuchtenberger M, Kraus L, Nigg A, Schulze-Koops H, Schäfer A. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study). Rheumatol Int 2021;41:1079-87. [PMID: 33608744 DOI: 10.1007/s00296-021-04804-8] [Reference Citation Analysis]
74 Boelsterli UA. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 343-67. [DOI: 10.1016/b978-0-12-387817-5.00021-2] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
75 Dragovic S, Venkataraman H, Begheijn S, Vermeulen NP, Commandeur JN. Effect of human glutathione S-transferase hGSTP1-1 polymorphism on the detoxification of reactive metabolites of clozapine, diclofenac and acetaminophen. Toxicology Letters 2014;224:272-81. [DOI: 10.1016/j.toxlet.2013.10.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
76 Chen HL, Lin SC, Li S, Tang KT, Lin CC. Alantolactone alleviates collagen-induced arthritis and inhibits Th17 cell differentiation through modulation of STAT3 signalling. Pharm Biol 2021;59:134-45. [PMID: 33556301 DOI: 10.1080/13880209.2021.1876102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol 2011;7:e1002310. [PMID: 22194678 DOI: 10.1371/journal.pcbi.1002310] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
78 Björnsson ES, Aithal GP. Immune-Mediated Drug-Induced Liver Injury. In: Gershwin ME, Vierling JM, Manns MP, editors. Liver Immunology. Cham: Springer International Publishing; 2014. pp. 401-12. [DOI: 10.1007/978-3-319-02096-9_27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Gelfand JM, Wan J, Zhang H, Shin DB, Ogdie A, Syed MN, Egeberg A. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study. J Am Acad Dermatol 2021;84:1636-43. [PMID: 33607181 DOI: 10.1016/j.jaad.2021.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
80 Kim M, Katz S, Green J. Drug Management in the Elderly IBD Patient. Curr Treat Options Gastroenterol 2015;13:90-104. [PMID: 25617139 DOI: 10.1007/s11938-014-0039-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
81 de Vries HS, de Heij T, Roelofs HM, te Morsche RH, Peters WH, de Jong DJ. Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro. Dig Dis Sci 2012;57:1604-8. [PMID: 22535279 DOI: 10.1007/s10620-012-2159-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
82 Akyol S, Ugurcu V, Altuntas A, Hasgul R, Cakmak O, Akyol O. Caffeic acid phenethyl ester as a protective agent against nephrotoxicity and/or oxidative kidney damage: a detailed systematic review. ScientificWorldJournal 2014;2014:561971. [PMID: 25003138 DOI: 10.1155/2014/561971] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
83 Chung S, Huang W, Huang C, Liu F, Huang R, Wu C, Lee A. Synthesis and anti-inflammatory activities of 4H-chromene and chromeno[2,3-b]pyridine derivatives. Res Chem Intermed 2016;42:1195-215. [DOI: 10.1007/s11164-015-2081-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 4.6] [Reference Citation Analysis]
84 Taskin B, Erdoğan MA, Yiğittürk G, Alper S, Erbaş O. An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment. Gastroenterol Res Pract 2021;2021:6619844. [PMID: 34804155 DOI: 10.1155/2021/6619844] [Reference Citation Analysis]
85 Kim TY, Kim JY, Sohn JH, Lee HS, Bang SY, Kim Y, Kim MY, Jeong WK. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis. J Ultrasound Med 2015;34:1621-30. [PMID: 26269292 DOI: 10.7863/ultra.15.14.10035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
86 Chertoff J, Alam S, Black M, Elgendy IY. Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. BMJ Case Rep. 2014;2014. [PMID: 25471111 DOI: 10.1136/bcr-2014-206859] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
87 Grželj J, Mlinarič-Raščan I, Marko PB, Marovt M, Gmeiner T, Šmid A. Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasis. Biomed Pharmacother 2021;138:111456. [PMID: 33714108 DOI: 10.1016/j.biopha.2021.111456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 Akhlaghi S, Sahebari M, Mahmoodi M, Yaseri M, Mansournia MA, Rafatpanah H, Zeraati H. Additional effect of etanercept or infliximab on the liver function tests of patients with rheumatoid arthritis: a cohort study. Ther Clin Risk Manag 2018;14:1943-50. [PMID: 30349273 DOI: 10.2147/TCRM.S172836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Wang W, Zhou H, Liu L. The role of Chinese herbal medicine in the management of adverse drug reactions of leflunomide in treating rheumatoid arthritis. Phytomedicine 2020;68:153136. [DOI: 10.1016/j.phymed.2019.153136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
90 Anelli MG, Scioscia C, Grattagliano I, Lapadula G. Old and new antirheumatic drugs and the risk of hepatotoxicity. Ther Drug Monit. 2012;34:622-628. [PMID: 23128910 DOI: 10.1097/ftd.0b013e31826a6306] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
91 Burton MJ, Curtis JR, Yang S, Chen L, Singh JA, Mikuls TR, Winthrop KL, Baddley JW. Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study. Arthritis Res Ther 2015;17:136. [PMID: 26001631 DOI: 10.1186/s13075-015-0628-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
92 Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel) 2021;10:390. [PMID: 33807700 DOI: 10.3390/antiox10030390] [Reference Citation Analysis]
93 van Swelm RP, Laarakkers CM, Pertijs JC, Verweij V, Masereeuw R, Russel FG. Urinary proteomic profiling reveals diclofenac-induced renal injury and hepatic regeneration in mice. Toxicology and Applied Pharmacology 2013;269:141-9. [DOI: 10.1016/j.taap.2013.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
94 Venkataraman H, den Braver MW, Vermeulen NP, Commandeur JN. Cytochrome P450-mediated bioactivation of mefenamic acid to quinoneimine intermediates and inactivation by human glutathione S-transferases. Chem Res Toxicol 2014;27:2071-81. [PMID: 25372302 DOI: 10.1021/tx500288b] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
95 Matsuo K, Sasaki E, Higuchi S, Takai S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury. Toxicol Lett 2014;224:215-24. [PMID: 24184165 DOI: 10.1016/j.toxlet.2013.10.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]